Steven Schoch
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Steven Schoch hat die Position des Chief Financial & Accounting Officer der 23andMe Holding Co. und des Chief Financial & Accounting Officer der 23andMe, Inc. (einer Tochtergesellschaft der 23andMe Holding Co.). Herr Schoch ist auch Mitglied des Vorstands von Arena Pharmaceuticals, Inc. In seiner früheren Laufbahn war Herr Schoch als Controller & Divisional Chief Financial Officer bei Amgen, Inc. tätig, als Executive VP, Chief Executive & Financial Officer bei Miramax Film NY LLC und als Chief Financial Officer & Executive Vice President von eToys Inc. Herr Schoch erwarb einen Bachelor-Abschluss an der Tufts University und einen MBA an der Tuck School of Business in Dartmouth.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ZURA BIO LIMITED | Direktor/Vorstandsmitglied | 01.03.2023 |
Pegasus Tech Ventures, Inc.
Pegasus Tech Ventures, Inc. Investment ManagersFinance Pegasus Tech Ventures invests in companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Berater | - |
Reflexion Networks, Inc.
Reflexion Networks, Inc. Packaged SoftwareTechnology Services Provides hosted email services | Finanzdirektor/CFO | 01.11.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
FLYR, Inc.
FLYR, Inc. Packaged SoftwareTechnology Services Provides AI-powered revenue management solutions for travel and transportation | Finanzdirektor/CFO | 20.02.2025 |
| CHROME HOLDING CO. | Finanzdirektor/CFO | 01.09.2022 |
| ARENA PHARMACEUTICALS | Direktor/Vorstandsmitglied | 11.03.2022 |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Finanzdirektor/CFO | 01.06.2021 |
Miramax Film NY LLC
Miramax Film NY LLC Movies/EntertainmentConsumer Services Produces and distributes movies | Vorstandsvorsitzender | 01.01.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
eToys, Inc.
eToys, Inc. Discount StoresRetail Trade Retails toys and games | Retail Trade |
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Reflexion Networks, Inc.
Reflexion Networks, Inc. Packaged SoftwareTechnology Services Provides hosted email services | Technology Services |
Miramax Film NY LLC
Miramax Film NY LLC Movies/EntertainmentConsumer Services Produces and distributes movies | Consumer Services |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Health Technology |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pegasus Tech Ventures, Inc.
Pegasus Tech Ventures, Inc. Investment ManagersFinance Pegasus Tech Ventures invests in companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
FLYR, Inc.
FLYR, Inc. Packaged SoftwareTechnology Services Provides AI-powered revenue management solutions for travel and transportation | Technology Services |
23andMe Holding Co.
23andMe Holding Co. BiotechnologyHealth Technology Operates as a genetic testing company | Health Technology |
Zura Bio Ltd.
Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen